LCTX
Lineage Cell Therapeutics Inc
0.9476$
+1.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +94.4% | -50.0% | +0.5% | +21.5% | +22.9% | -34.1% | +61.6% | -56.4% | -35.2% | +4.7% | +39.7% | -13.2% | +283.4% | -80.0% | -40.4% | +245.5% | -51.5% | +76.5% | +50.5% | +399.3% | -56.4% | +445.5% | -13.1% | -34.2% | -36.1% | +24.6% | +35.2% | -61.4% | +67.6% | -30.8% | -2.5% | +168.4% | -24.1% | -47.6% | +84.1% | +33.1% | +79.5% | -73.9% | -38.0% | – | |
| – | -65.5% | +185.0% | -91.2% | +940.0% | +3.8% | +101.9% | -2.8% | -67.0% | +48.6% | +30.8% | +57.4% | +6.5% | +7.9% | -23.6% | -20.2% | +36.0% | +11.8% | -1.8% | +11.6% | +688.0% | -79.3% | -13.7% | +22.2% | +9.3% | -56.6% | +16.7% | +6.7% | +33.1% | +155.0% | -36.7% | -83.9% | -13.6% | +305.3% | -76.6% | +8.3% | -87.2% | +1,220.0% | +184.8% | -0.5% | – | |
| – | +122.3% | -56.4% | +16.8% | +9.3% | +25.3% | -48.3% | +88.0% | -54.2% | -48.0% | -6.7% | +28.8% | -28.0% | +588.3% | -89.8% | -66.7% | +900.0% | -78.3% | +248.1% | +74.6% | +285.1% | -37.9% | +569.4% | -14.3% | -36.3% | -34.4% | +25.0% | +36.7% | -65.2% | +53.9% | -29.3% | +16.5% | +174.3% | -27.5% | -46.0% | +85.9% | +34.8% | +78.0% | -76.5% | -42.6% | – | |
| – | +9.2% | -7.4% | -3.4% | +4.6% | -28.4% | +26.4% | +7.1% | -23.2% | -22.6% | +31.2% | +5.5% | -18.5% | -18.3% | -4.2% | -16.0% | +27.1% | -26.9% | +30.2% | -13.6% | -4.1% | +781.5% | -87.9% | +10.5% | +8.8% | +14.3% | +2.0% | -7.5% | -3.4% | +3.6% | -22.9% | -4.0% | +10.6% | +7.9% | -9.0% | -0.3% | +5.3% | +151.8% | -48.6% | +12.8% | – | |
| – | +16.8% | -4.5% | -13.3% | +3.7% | +26.7% | +4.0% | -13.5% | +22.9% | +9.5% | +23.1% | -27.7% | -26.4% | -2.3% | +0.3% | -13.5% | -7.2% | -3.1% | +11.9% | +15.3% | +17.2% | -16.8% | +91.4% | -37.8% | -16.1% | -1.7% | +8.6% | -10.1% | -4.9% | +6.1% | +16.5% | -12.7% | +1.1% | -0.2% | +10.4% | -6.1% | -8.1% | +15.8% | +4.8% | +2.6% | – | |
| – | +21.7% | -3.7% | -7.7% | -7.2% | +1.6% | +15.6% | -17.2% | +9.8% | -3.4% | +25.9% | -14.8% | -22.2% | -11.1% | -0.9% | -14.4% | +8.4% | -14.8% | +21.9% | +2.3% | +9.0% | +259.7% | -60.5% | -25.2% | -6.5% | +5.5% | +5.4% | -8.8% | -4.2% | +3.0% | -2.3% | -7.7% | +4.8% | +3.2% | +1.9% | +182.3% | -66.8% | +75.4% | -30.3% | +7.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +40.1% | +30.8% | +4,133.3% | -99.9% | +1,346,980.0% | -22.4% | -95.7% | +1,609.7% | -9.0% | +34.5% | -55.1% | -54.7% | -87.1% | -83.6% | -6.2% | -33.7% | -99.2% | +0.0% | +50.0% | -66.7% | +200.0% | -66.7% | +5,000.0% | +652.9% | -27.9% | +57.0% | -12.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -126.5% | – | -131.6% | – | -509.7% | – | – | – | -168.1% | – | -189.7% | – | – | – | – | – | – | -247.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -200.0% | – | -200.0% | – | -109.3% | – | – | – | – | – | – | – | – | -112.5% | – | – | – | – | – | +1.9% | +164.5% | -83.0% | -57.5% | -883.9% | – | – | – | -126.2% | – | – | -69.7% | – | – | – | – | – | – | – | |
| – | -116.3% | – | -123.6% | – | -602.3% | – | – | – | -167.4% | – | -176.4% | – | – | – | – | – | – | -169.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -665.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.